JP2003513062A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003513062A5 JP2003513062A5 JP2001534755A JP2001534755A JP2003513062A5 JP 2003513062 A5 JP2003513062 A5 JP 2003513062A5 JP 2001534755 A JP2001534755 A JP 2001534755A JP 2001534755 A JP2001534755 A JP 2001534755A JP 2003513062 A5 JP2003513062 A5 JP 2003513062A5
- Authority
- JP
- Japan
- Prior art keywords
- sertraline
- solution
- polymorph form
- hydrogen chloride
- seed crystal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99810981.3 | 1999-10-29 | ||
| EP99810981 | 1999-10-29 | ||
| PCT/EP2000/010416 WO2001032601A1 (en) | 1999-10-29 | 2000-10-23 | Polymorphic forms of sertraline hydrochloride |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003513062A JP2003513062A (ja) | 2003-04-08 |
| JP2003513062A5 true JP2003513062A5 (enExample) | 2007-12-06 |
Family
ID=8243113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001534755A Withdrawn JP2003513062A (ja) | 1999-10-29 | 2000-10-23 | 塩酸セルトラリンの多形形態 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6872853B1 (enExample) |
| EP (1) | EP1224160B1 (enExample) |
| JP (1) | JP2003513062A (enExample) |
| CN (1) | CN1384816A (enExample) |
| AR (1) | AR026293A1 (enExample) |
| AT (1) | ATE409684T1 (enExample) |
| AU (1) | AU1386301A (enExample) |
| CA (1) | CA2387135A1 (enExample) |
| DE (1) | DE60040406D1 (enExample) |
| HU (1) | HUP0203559A3 (enExample) |
| IL (2) | IL149050A0 (enExample) |
| MX (1) | MXPA02004255A (enExample) |
| MY (1) | MY141509A (enExample) |
| TR (1) | TR200201146T2 (enExample) |
| TW (1) | TWI260315B (enExample) |
| WO (1) | WO2001032601A1 (enExample) |
| ZA (1) | ZA200203254B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1632472A1 (en) * | 1998-11-27 | 2006-03-08 | Teva Pharmaceutical Industries Ltd | Sertraline hydrochloride polymorphs |
| US6500987B1 (en) * | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| DE69929462T2 (de) * | 1998-11-27 | 2006-09-07 | Teva Pharmaceutical Industries Ltd. | Sertralin hydrochlorid form |
| US6495721B1 (en) | 1999-08-09 | 2002-12-17 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride Form II and methods for the preparation thereof |
| US7442838B2 (en) * | 1999-10-29 | 2008-10-28 | Ciba Specialty Chemicals Corp. | Polymorphic forms of sertraline hydrochloride |
| US20050119351A1 (en) * | 1999-10-29 | 2005-06-02 | Van Der Schaaf Paul A. | Polymorphic forms of sertraline hydrochloride |
| WO2001045692A1 (en) * | 1999-12-21 | 2001-06-28 | Teva Pharmaceutical Industries Ltd. | Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them |
| EP1772144A3 (en) * | 1999-12-21 | 2007-08-15 | Teva Pharmaceutical Industries Ltd | Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them |
| IN192343B (enExample) * | 2000-05-26 | 2004-04-10 | Ranbaxy Lab Ltd | |
| CA2448279A1 (en) | 2001-05-31 | 2002-12-05 | Orion Corporation Fermion | Process for preparing sertraline hydrochloride polymorphic form ii |
| WO2003093217A1 (en) * | 2002-04-29 | 2003-11-13 | Teva Pharmaceutical Industries Ltd. | Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof |
| MXPA04011375A (es) * | 2002-06-27 | 2005-02-14 | Interdigital Tech Corp | Controlador de red de radio para intercambio de informacion de equipo. |
| WO2005000786A1 (en) | 2003-05-23 | 2005-01-06 | Transform Pharmaceuticals, Inc. | Sertraline compositions |
| US7893300B2 (en) | 2003-11-04 | 2011-02-22 | Cipla Limited | Process for the preparation of polymorphs of selective serotonin reuptake inhibitor |
| WO2005075467A2 (en) * | 2004-02-06 | 2005-08-18 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of zolmitriptan |
| WO2007008317A2 (en) * | 2005-06-09 | 2007-01-18 | Teva Pharmaceutical Industries Ltd. | Process for preparation of sertraline hydrochloride form i |
| US7518019B2 (en) | 2006-06-01 | 2009-04-14 | Hetero Drugs Limited | Processes for preparing sertraline hydrochloride crystalline forms |
| CA2594198A1 (en) * | 2007-07-20 | 2009-01-20 | Apotex Pharmachem Inc. | A novel process for the preparation of sertraline hydrochloride form ii |
| US9186642B2 (en) | 2010-04-28 | 2015-11-17 | The Procter & Gamble Company | Delivery particle |
| US9993793B2 (en) | 2010-04-28 | 2018-06-12 | The Procter & Gamble Company | Delivery particles |
| CN103458871B (zh) | 2011-04-07 | 2015-05-13 | 宝洁公司 | 具有增强的聚丙烯酸酯微胶囊的沉积的调理剂组合物 |
| WO2012138710A2 (en) | 2011-04-07 | 2012-10-11 | The Procter & Gamble Company | Personal cleansing compositions with increased deposition of polyacrylate microcapsules |
| WO2012138696A2 (en) | 2011-04-07 | 2012-10-11 | The Procter & Gamble Company | Shampoo compositions with increased deposition of polyacrylate microcapsules |
| CN105061217A (zh) * | 2015-06-30 | 2015-11-18 | 徐静 | 枸橼酸舍曲林的2种晶型及其制备方法 |
| CA3194468A1 (en) | 2020-10-16 | 2022-04-21 | Johan Smets | Consumer product compositions comprising a population of encapsulates |
| MX2023004232A (es) | 2020-10-16 | 2023-04-21 | Procter & Gamble | Composiciones de productos de consumo con al menos dos poblaciones de encapsulados. |
| US12486478B2 (en) | 2020-10-16 | 2025-12-02 | The Procter & Gamble Company | Consumer products comprising delivery particles with high core:wall ratios |
| CN112552188B (zh) * | 2020-12-17 | 2023-07-28 | 山西仟源医药集团股份有限公司 | 盐酸舍曲林晶型i的制备方法 |
| CN113588626B (zh) * | 2021-08-24 | 2024-05-24 | 上海师范大学 | 一种苯丙氨酸对映体的拉曼光谱检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536518A (en) | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| US5082970A (en) | 1991-03-06 | 1992-01-21 | Pfizer Inc. | Process for recycling amine isomer |
| GB9114947D0 (en) | 1991-07-11 | 1991-08-28 | Pfizer Ltd | Process for preparing sertraline |
| US5248699A (en) | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
| US5734083A (en) | 1996-05-17 | 1998-03-31 | Torcan Chemical Ltd. | Sertraline polymorph |
| HU222341B1 (hu) | 1996-12-18 | 2003-06-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás sertralin előállítására és az eljárásban alkalmazott intermedier |
| DE69713353D1 (de) * | 1997-12-11 | 2002-07-18 | Torcan Chemical Ltd | Sertralin-Polymorph mit verbesserter Wasserlöslichkeit |
| CA2323629A1 (en) | 1998-03-18 | 1999-09-23 | Ciba Specialty Chemicals Holding Inc. | Process for the cis-selective catalytic hydrogenation of cyclohexylidenamines |
| JP2000026378A (ja) | 1998-07-03 | 2000-01-25 | Sumika Fine Chemicals Co Ltd | 塩酸セルトラリンの製法 |
| DE69929462T2 (de) | 1998-11-27 | 2006-09-07 | Teva Pharmaceutical Industries Ltd. | Sertralin hydrochlorid form |
| US6500987B1 (en) | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| US6495721B1 (en) | 1999-08-09 | 2002-12-17 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride Form II and methods for the preparation thereof |
| WO2001045692A1 (en) | 1999-12-21 | 2001-06-28 | Teva Pharmaceutical Industries Ltd. | Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them |
-
2000
- 2000-10-07 TW TW089120975A patent/TWI260315B/zh not_active IP Right Cessation
- 2000-10-20 MY MYPI20004969A patent/MY141509A/en unknown
- 2000-10-23 JP JP2001534755A patent/JP2003513062A/ja not_active Withdrawn
- 2000-10-23 CN CN00815052A patent/CN1384816A/zh active Pending
- 2000-10-23 HU HU0203559A patent/HUP0203559A3/hu unknown
- 2000-10-23 DE DE60040406T patent/DE60040406D1/de not_active Expired - Fee Related
- 2000-10-23 US US10/111,947 patent/US6872853B1/en not_active Expired - Fee Related
- 2000-10-23 EP EP00975896A patent/EP1224160B1/en not_active Expired - Lifetime
- 2000-10-23 IL IL14905000A patent/IL149050A0/xx active IP Right Grant
- 2000-10-23 AU AU13863/01A patent/AU1386301A/en not_active Abandoned
- 2000-10-23 WO PCT/EP2000/010416 patent/WO2001032601A1/en not_active Ceased
- 2000-10-23 AT AT00975896T patent/ATE409684T1/de not_active IP Right Cessation
- 2000-10-23 CA CA002387135A patent/CA2387135A1/en not_active Abandoned
- 2000-10-23 MX MXPA02004255A patent/MXPA02004255A/es active IP Right Grant
- 2000-10-23 TR TR2002/01146T patent/TR200201146T2/xx unknown
- 2000-10-27 AR ARP000105711A patent/AR026293A1/es not_active Application Discontinuation
-
2002
- 2002-04-09 IL IL149050A patent/IL149050A/en not_active IP Right Cessation
- 2002-04-24 ZA ZA200203254A patent/ZA200203254B/xx unknown
-
2003
- 2003-12-15 US US10/736,195 patent/US6939992B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003513062A5 (enExample) | ||
| TWI320040B (en) | Polymorphs of an epothilone analog | |
| CA2284750A1 (en) | Steroid sulfamates, method for the production and use thereof | |
| ES2170732B2 (es) | Procedimiento para preparar citalopram purificado | |
| MXPA05008172A (es) | Derivados de malonamida como inhibidores gamma-secretasa. | |
| ZA200410000B (en) | Method for producing C13-alcohol mixtures | |
| RU2007113811A (ru) | Способ получения оптически активных производных амина | |
| ZA9710255B (en) | Crystals of benzimidazole derivatives and their production | |
| JP2006519246A5 (ja) | 高純度フォンダパリヌクスナトリウム組成物 | |
| MY141509A (en) | Polymoprphic forms of sertraline hydrochloride | |
| AR039857A1 (es) | Preparaciones de una sulfinilacetamida | |
| JP2002517370A5 (enExample) | ||
| PE20040767A1 (es) | Derivado hemisulfato de azido citosina cristalino anhidro | |
| JP2002538165A5 (enExample) | ||
| JP2001524525A5 (enExample) | ||
| CA2521877A1 (fr) | Nouveau procede de synthese de l'acide (2s)-indoline-2-carboxylique, et application a la synthese du perindopril | |
| JP2003012683A5 (enExample) | ||
| HUP9902783A2 (hu) | Polimorf zopolresztát monohidrát, eljárás előállítására és a vegyület gyógyászati alkalmazásai | |
| KR900009596A (ko) | N-피리디닐-9h-카바졸-9-아민, 이의 제조방법 및 이의 약제로서의 용도 | |
| JP2005255587A5 (enExample) | ||
| Bennett et al. | The Enzymatic Synthesis of N-Acyl-D-and L-Phenylalanylphenylhydrazides1 | |
| JP2001513770A (ja) | ベンゾチアゾロン化合物の製造方法 | |
| JP2003515536A5 (enExample) | ||
| SE0201938D0 (sv) | New process | |
| PT89742B (pt) | Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas |